Nitric Oxide Signaling

Core Concept

Nitric oxide (NO) is an unusual signaling molecule: a small, freely diffusible gas synthesized on demand from the amino acid arginine by nitric oxide synthase (NOS). Because it diffuses straight through membranes, it acts locally (paracrine) on neighboring cells — most importantly on smooth muscle, where it causes relaxation and vasodilation. NO's receptor is not on the cell surface or in the nucleus but a cytoplasmic enzyme, soluble guanylyl cyclase (sGC), whose heme iron NO binds directly. Activation of sGC converts GTP to the second messenger cGMP, which activates protein kinase G (PKG), lowering intracellular Ca²⁺ and relaxing muscle. NO is short-lived (half-life of seconds), so its signal is rapid, local, and tightly controlled.

Key Components

• Nitric oxide synthase (NOS): the enzyme that produces NO from L-arginine + O₂ → citrulline + NO, using NADPH. Isoforms: eNOS (endothelial), nNOS (neuronal), iNOS (inducible, immune).
• L-arginine: the substrate; citrulline the co-product.
• Soluble guanylyl cyclase (sGC): a cytoplasmic heterodimer with a heme (iron) prosthetic group that is NO's actual binding site.
• cGMP: the second messenger made from GTP by sGC.
• Protein kinase G (PKG): the cGMP-dependent kinase that phosphorylates targets (e.g., to reduce cytosolic Ca²⁺ in smooth muscle).
• Phosphodiesterase 5 (PDE5): the enzyme that degrades cGMP, terminating the signal.

Mechanism / How It Works

1. A stimulus — acetylcholine on endothelial cells, glutamate in neurons, or inflammatory cytokines in macrophages — raises intracellular Ca²⁺, activating NOS.
2. NOS converts arginine + O₂ → citrulline + NO (using NADPH and cofactors).
3. NO, being a small gas, diffuses across membranes into nearby target cells.
4. In the target cell, NO binds the heme iron of sGC, triggering a conformational change that activates the cyclase.
5. Active sGC converts GTP → cGMP, raising cGMP concentration hundreds-fold.
6. cGMP activates PKG, which phosphorylates proteins that reduce cytosolic Ca²⁺ and desensitize the contractile machinery, causing smooth-muscle relaxation (vasodilation).
7. PDE5 hydrolyzes cGMP to GMP, and NO is oxidized (half-life ~2–5 seconds), quickly ending the signal.

Energy and Directionality

NO synthesis consumes NADPH (reducing power) and O₂; cGMP production consumes GTP; and the Ca²⁺-pump/kinase machinery that executes relaxation consumes ATP. Directionality is spatial and chemical: NO is produced only by NOS-expressing cells and acts only on cells expressing sGC/PKG, and its short half-life confines the message to a small volume around the source — an inherently directional, local signal with a rapid on/off.

Experimental Evidence / Technique

• Vasodilation bioassays: Furchgott and colleagues showed that endothelial-derived relaxing factor (EDRF) relaxes aortic rings only when the endothelium is present; EDRF was later identified as NO (1998 Nobel Prize).
• Griess assay / chemiluminescence: detects nitrite/nitrate and NO directly, quantifying NO production.
• sGC/cGMP measurements: NO donors (e.g., sodium nitroprusside) raise cGMP in target cells, linking NO → sGC → cGMP.
• Heme binding / spectroscopy: NO binds the sGC heme iron, changing its absorbance spectrum — direct evidence of the NO–heme interaction.
• Knockout/knockin mice: eNOS⁻/⁻ mice are hypertensive; sGC or PKG disruption blocks NO-dependent relaxation, confirming each pathway step in vivo.

How it works

1. A stimulus — acetylcholine on endothelial cells, glutamate in neurons, or inflammatory cytokines in macrophages — raises intracellular Ca²⁺, activating NOS.
2. NOS converts arginine + O₂ → citrulline + NO (using NADPH and cofactors).
3. NO, being a small gas, diffuses across membranes into nearby target cells.
4. In the target cell, NO binds the heme iron of sGC, triggering a conformational change that activates the cyclase.
5. Active sGC converts GTP → cGMP, raising cGMP concentration hundreds-fold.
6. cGMP activates PKG, which phosphorylates proteins that reduce cytosolic Ca²⁺ and desensitize the contractile machinery, causing smooth-muscle relaxation (vasodilation).
7. PDE5 hydrolyzes cGMP to GMP, and NO is oxidized (half-life ~2–5 seconds), quickly ending the signal.

Common confusions

• "NO is a hormone acting through a nuclear receptor." — NO is a gas acting on the cytoplasmic enzyme sGC; it never binds a nuclear receptor.
• "NO's receptor is a 7TM/GPCR." — No; sGC is a soluble cytoplasmic cyclase, not a transmembrane receptor.
• "NO works by binding DNA." — It works by activating sGC → cGMP → PKG (though NO can also nitrosylate proteins, a distinct action).
• "cGMP is made from ATP." — cGMP is made from GTP (cAMP is the one made from ATP).
• "NO is a long-range hormone." — Its extreme lability makes it strictly local/paracrine.

Quick review

• NO = diffusible gas, made by NOS (e/n/i) from arginine, NADPH, O₂.
• Pathway: NO → sGC (heme) → GTP → cGMP → PKG → vasodilation.
• Short half-life (~seconds) → local, rapid, tightly controlled signaling.
• NOT a nuclear receptor or GPCR; distinct from steroid hormones.
• Drugs: nitroglycerin (NO donor), sildenafil (PDE5 inhibitor).
• Roles: vascular tone, neurotransmission, immune killing; defects → hypertension, septic shock.